Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Hippocampus Välmående & Invest AB
AB
Active
Org 5591077689
Henrik Trollesgatan 17, 371 36
Karlskrona
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2017
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Hippocampus Välmående & Invest AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
122
82
103
163
106
Staff expenses
—
—
—
—
—
EBITDA
98
56
81
135
67
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
98
56
81
135
67
Net financials
−1
609
—
79
200
Profit before tax
73
689
61
181
251
Tax
−15
−0
−12
−21
−11
Net profit
58
689
49
160
240
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
539
889
963
1 175
1 409
Equity
171
860
908
1 068
1 308
Long-term debt
0
0
0
0
0
Short-term debt
344
29
35
54
32
Total debt
344
29
35
54
32
Financial ratios
5-year trend
EBITDA margin
63.2%
This company
15.8%
Market median
+300% vs market
2021
2025
Equity ratio
92.8%
This company
38.2%
Market median
+143% vs market
2021
2025
Return on equity
18.3%
This company
18.4%
Market median
+1% vs market
2021
2025
Net profit margin
226.4%
This company
8.1%
Market median
+2695% vs market
2021
2025
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
2021
2025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Hippocampus Välmående & Invest AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
